NAOV - NanoVibronix Inc Stock Price, Fair Value and News

0.75USD+0.02 (+2.74%)Market Closed

Market Summary

USD0.75+0.02

Market Closed

2.74%

NAOV Stock Price

View Fullscreen

NAOV RSI Chart

NAOV Valuation

Market Cap

2.1M

Price/Earnings (Trailing)

-0.65

Price/Sales (Trailing)

0.73

EV/EBITDA

0.2

Price/Free Cashflow

-0.7

NAOV Price/Sales (Trailing)

NAOV Profitability

Operating Margin

68.98%

EBT Margin

-111.16%

Return on Equity

-91.38%

Return on Assets

-51.36%

Free Cashflow Yield

-142.8%

NAOV Fundamentals

NAOV Revenue

Revenue (TTM)

2.9M

Rev. Growth (Yr)

160.17%

Rev. Growth (Qtr)

-21.75%

NAOV Earnings

Earnings (TTM)

-3.2M

Earnings Growth (Yr)

46.4%

Earnings Growth (Qtr)

27.68%

Breaking Down NAOV Revenue

Last 7 days

-1.3%

Last 30 days

1.4%

Last 90 days

-1.3%

Trailing 12 Months

-76.8%

How does NAOV drawdown profile look like?

NAOV Financial Health

Current Ratio

2.45

NAOV Investor Care

Shares Dilution (1Y)

67.50%

Diluted EPS (TTM)

-1.68

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.9M	0	0	0
2023	1.1M	1.5M	1.9M	2.3M
2022	1.9M	2.0M	1.6M	752.0K
2021	612.0K	661.0K	1.0M	1.7M
2020	565.0K	571.0K	620.0K	623.0K
2019	319.5K	450.5K	497.5K	530.0K
2018	264.0K	344.0K	333.0K	317.5K
2017	224.0K	214.0K	218.0K	239.0K
2016	175.0K	198.0K	219.0K	229.0K
2015	189.0K	175.0K	161.0K	147.0K
2014	0	0	0	203.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About NanoVibronix Inc

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

CEO	Mr. Brian M. Murphy
WEBSITE	nanovibronix.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	9

NanoVibronix Inc Frequently Asked Questions

What is the ticker symbol for NanoVibronix Inc? What does NAOV stand for in stocks?

NAOV is the stock ticker symbol of NanoVibronix Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NanoVibronix Inc (NAOV)?

As of Fri Jul 26 2024, market cap of NanoVibronix Inc is 2.09 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NAOV stock?

You can check NAOV's fair value in chart for subscribers.

Is NanoVibronix Inc a good stock to buy?

The fair value guage provides a quick view whether NAOV is over valued or under valued. Whether NanoVibronix Inc is cheap or expensive depends on the assumptions which impact NanoVibronix Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NAOV.

What is NanoVibronix Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, NAOV's PE ratio (Price to Earnings) is -0.65 and Price to Sales (PS) ratio is 0.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NAOV PE ratio will change depending on the future growth rate expectations of investors.